Supply Chain | May 02, 2026
IMCD posts steady Q1 2026 performance with €130 million EBITA amid global uncertainty
The company posted revenue of €1,267 million, up 6% on a constant currency basis
The company posted revenue of €1,267 million, up 6% on a constant currency basis
The microbiology unit generated $645 million in revenue in 2025 and sits within Thermo Fisher’s Specialty Diagnostics segment
But acquisition charges drag earnings into loss
The company posted revenue of Rs. 703 crore in Q4 FY26
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Study introduces structured, condition-specific emergency coding system to improve coordination, response time, and patient safety in tertiary care hospitals
The deal, backed by healthcare investor ARCHIMED, signals a major push to accelerate connected, patient-centered cardiac care worldwide
His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia
Wadhwa brings over two decades of experience driving growth, transformation, and customer-centric strategies in the medical devices and diagnostics sector
Subscribe To Our Newsletter & Stay Updated
